1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Shanghai Yizhong Pharmaceutical Co., Ltd.

Shanghai Yizhong Pharmaceutical Co., Ltd.

688091.SS
Shanghai Yizhong Pharmaceutical Co., Ltd.CN flagShanghai Stock Exchange
48.11
CNY
+3.68
- -
9.94BMarket Cap

Total Valuation

Shanghai Yizhong Pharmaceutical Co., Ltd. carries a market capitalization of 9.94B, placing it among publicly traded companies globally. Its enterprise value stands at 8.94B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap9.94B
Enterprise Value8.94B

Share Statistics

Shanghai Yizhong Pharmaceutical Co., Ltd. currently has 206.70M shares outstanding.

Shares Outstanding206.70M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Shanghai Yizhong Pharmaceutical Co., Ltd. trades at a trailing price-to-earnings ratio of 905.46. The price-to-sales ratio is 44.74, and the price-to-book ratio stands at 23.20.

PE Ratio905.46
PS Ratio44.74
PB Ratio23.20
P/TBV Ratio6.59
P/FCF Ratio67.82
P/OCF RatioN/A

Enterprise Valuation

EV / Sales42.17
EV / EBITDAN/A
EV / EBITN/A
EV / FCF63.84

Financial Position

Shanghai Yizhong Pharmaceutical Co., Ltd. maintains a current ratio of 17.10, meaning it holds 17.1x the short-term assets needed to cover near-term liabilities.

Current Ratio17.10
Quick Ratio12.45
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage-111.48

Financial Efficiency

Return on Equity (ROE)2.60
Return on Assets (ROA)0.69
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)0.75
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.79

Taxes

Over the trailing twelve months, Shanghai Yizhong Pharmaceutical Co., Ltd. has paid -4.42M in income taxes, reflecting an effective tax rate of 11.89.

Income Tax-4.42M
Effective Tax Rate11.89

Stock Price Statistics

Shanghai Yizhong Pharmaceutical Co., Ltd.'s stock has declined approximately -20.00333% over the past 52 weeks. The 50-day moving average sits at 50.11, while the 200-day moving average is 52.26.

Beta (5Y)N/A
52-Week Price Change-20.00333%
50-Day Moving Average50.11
200-Day Moving Average52.26
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Shanghai Yizhong Pharmaceutical Co., Ltd. generated 211.92M in revenue and converted that into 10.47M in net income, yielding earnings per share of 0.05. EBITDA reached -12.03M, while operating income came in at -12.03M.

Revenue211.92M
Gross Profit177.24M
Operating Income-12.03M
Pretax Income6.05M
Net Income10.47M
EBITDA-12.03M
EBIT-12.03M
Earnings Per Share (EPS)0.05

Balance Sheet

Total book value stands at 408.72M, with working capital of 702.85M providing operational flexibility.

Cash & Cash Equivalents543.51M
Total DebtN/A
Net Debt-533.48M
Equity (Book Value)408.72M
Book Value Per Share2.02
Working Capital702.85M

Cash Flow

After subtracting -139.79M in capital expenditures, free cash flow totaled -139.79M - equivalent to -0.69 per share.

Operating Cash FlowN/A
Capital Expenditures-139.79M
Free Cash Flow-139.79M
FCF Per Share-0.69

Margins

Shanghai Yizhong Pharmaceutical Co., Ltd. operates with a gross margin of 83.64, reflecting its pricing power and cost economics. The operating margin of -5.68 and net profit margin of 4.94 provide insight into operational efficiency.

Gross Margin83.64
Operating Margin-5.68
Pretax Margin2.85
Profit Margin4.94
EBITDA Margin-5.68

Dividends & Yields

The company's payout ratio of 1.22 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.00
Dividend YieldN/A
Payout Ratio1.22
Shareholder Yield0.50
FCF Yield1.47

Stock Splits

Shanghai Yizhong Pharmaceutical Co., Ltd.'s most recent stock split took place on May 17, 2024 with a 10:13 split ratio.

Last Split Date5/17/2024
Split Ratio10:13

Scores

Shanghai Yizhong Pharmaceutical Co., Ltd. posts an Altman Z-Score of 122.40, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score122.40